Skip to content
Search

Latest Stories

Everyone with symptoms eligible for Covid-19 tests

The government has announced that anyone in the UK with symptoms of coronavirus is now eligible to book a test, ahead of the rollout of the test and trace service.

The expansion in testing eligibility comes after all four UK chief medical officers confirmed that anosmia has been added as a symptom of Covid-19. Anosmia is the loss of or a change in normal sense of smell, and it can also affect your sense of taste.


People have been asked to self-isolate immediately if they have a new, continuous cough, high temperature, or loss of or change in their normal sense of smell or taste.

The Department of Health and Social Care (DHSC) has said all members of the household must also self-isolate according to current guidelines, unless the symptomatic individual receives a negative test result.

Health and Social Care Secretary Matt Hancock commented: “Following the massive ramping up of our national testing programme, anybody with symptoms of coronavirus in the United Kingdom is now eligible for a test.

“This is a huge step forward in our plan to slow the spread of the virus, protect the NHS and give the peace of mind these tests can bring.

“We will continue to give priority to NHS staff and care home residents and workers in order to protect our most vulnerable.”

The tracing element of the service in England, due to be launched soon, will be supported by 21,000 contact tracers who have now been recruited, and will play a vital role working to reach those who have been in close contact with someone who has developed coronavirus.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less